Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
BACKGROUND: Composite tissue transplantation effectively reconstructs the most complex defects, but its use is limited because of harmful immunosuppression and the high susceptibility of skin to rejection. Development of tolerance is an ideal solution, and protocols using regulatory T cells (Tregs)...
Main Authors: | Issa, F, Hester, J, Goto, R, Nadig, SN, Goodacre, T, Wood, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
by: Wu, D, et al.
Published: (2013) -
Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model
by: Issa, F, et al.
Published: (2013) -
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
by: Nadig, SN, et al.
Published: (2010) -
Ex vivo expanded human treg inhibit the development of transplant arteriosclerosis in a humanized in vivo model
by: Nadig, SN, et al.
Published: (2008) -
Ex vivo-expanded human CD19+CD73-CD25+CD71+TIM-1+ B regulatory cells can prolong allograft survival in a humanized mouse model of skin transplantation and are dependent on TIM1-mediated regulation of STAT3 signaling
by: Shankar, S, et al.
Published: (2018)